Evidence map›Paper›PMID 36434323›Full record

ArticleEndocrine2023

Association between sensitivity to thyroid hormones and dyslipidemia in patients with coronary heart disease.

Yijia Liu, Mei Ma, Lin Li, Fanfan Liu, Zhu Li, Lu Yu, Tong Yang, Yang Wang, Shan Gao, Sheng Gao and 2 more

Abstract readMulticenter StudyComment
PubMed Publisher
In one paragraph

Article in Endocrine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Yijia LiuTianjin University of Traditional Chinese Medicine, Tianjin, 301617, China.
Mei MaTianjin University of Traditional Chinese Medicine, Tianjin, 301617, China.
Lin LiTianjin University of Traditional Chinese Medicine, Tianjin, 301617, China.
Fanfan LiuTianjin University of Traditional Chinese Medicine, Tianjin, 301617, China.
Zhu LiTianjin University of Traditional Chinese Medicine, Tianjin, 301617, China.
Lu YuTianjin University of Traditional Chinese Medicine, Tianjin, 301617, China.
Tong YangTianjin University of Traditional Chinese Medicine, Tianjin, 301617, China.
Yang WangTianjin University of Traditional Chinese Medicine, Tianjin, 301617, China.
Shan GaoTianjin University of Traditional Chinese Medicine, Tianjin, 301617, China.
Sheng GaoNankai Hospital: Tianjin Hospital of Integrated Traditional Chinese and Western Medicine, Tianjin, 300199, China. gaosheng6747@163.com.
Rongrong YangTianjin University of Traditional Chinese Medicine, Tianjin, 301617, China. rongrong0423@hotmail.com.
Chunquan YuTianjin University of Traditional Chinese Medicine, Tianjin, 301617, China. ycqtjutcm@foxmail.com.ORCID 0000-0002-0409-6762
Tianjin University of Traditional Chinese Medicine · CN

Funding

National Basic Research Program of China 2014CB542902
6 · The paper itself

Abstract

backgroundThyroid hormones affect lipid metabolism via central and peripheral regulation. However, there have been few studies on the association between thyroid hormone sensitivity and dyslipidemia. We aimed to investigate the association between thyroid hormone sensitivity and dyslipidemia in patients with coronary heart disease (CHD).

methodsA total of 31,678 patients with CHD were included in this large multicenter retrospective study. Central thyroid hormone sensitivity was evaluated using the thyroid feedback quantile-based index (TFQI), parametric thyroid feedback quantile-based index (PTFQI), thyroid-stimulating hormone index (TSHI), and thyrotropin thyroxine resistance index (TT4RI); peripheral thyroid hormone sensitivity was assessed by the ratio of free triiodothyronine (FT3)/free thyroxine (FT4). Logistic regression analysis was used to analyze the association between thyroid hormone sensitivity and dyslipidemia.

resultsAmong 31,678 participants, 21,648 (68.34%) had dyslipidemia. In the multi-adjusted models, the risk of dyslipidemia was positively correlated with TFQI (odds ratio [OR]: 1.04; 95% confidence interval [CI]: 1.03-1.05), PTFQI (OR: 1.09; 95% CI: 1.06-1.12), TSHI (OR: 1.08; 95% CI: 1.06-1.11), and TT4RI (OR: 1.08; 95% CI: 1.05-1.11). Conversely, the risk of dyslipidemia was negatively correlated with FT3/FT4 (OR: 0.94; 95% CI: 0.92-0.97). In stratified analyses, the association between thyroid hormone sensitivity and dyslipidemia was statistically significant for different sexes, glucose levels, and blood pressure states.

conclusionThere is a significant association between sensitivity to thyroid hormones and dyslipidemia, regardless of sex, glucose level, or blood pressure. Graphical abstract.

Indexed as

Coronary DiseaseDyslipidemiasThyroid Hormone Resistance SyndromeCongenital HypothyroidismGlucoseHumansRetrospective StudiesThyroid HormonesThyrotropinThyroxineTriiodothyronineGlucoseThyroid HormonesThyrotropinThyroxineTriiodothyronineCoronary heart diseaseDyslipidemiaElevated blood glucoseHypertensionResistance to thyroid hormonesThyroid hormone sensitivity

Identifiers

PMID36434323
OpenAlexW4309955072

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.